This months News in Brief deals with:
Women tend to overestimate their personal risk for getting breast cancer; Tamoxifen in decline; The many talents of raloxifene; EZH2 is involved in the progression of prostate cancer; The tumor-associated antigen RCAS1 (receptor-binding cancer antigen); Drug testing in ovarian cancer; Impact of false-positive mammography and subsequent cancer risk.
Go to Next Page